Caitlin Hyland

Patent Agent

  • Caitlin Hyland
  • Phone: +1 212 471 1848

    Import to Address Book

  • Duane Morris LLP
    1540 Broadway
    New York, NY 10036-4086

Caitlin Hyland, Ph.D. is a patent agent for Duane Morris’ Intellectual Property Practice Group. Dr. Hyland assists attorneys with the prosecution of patent and trademark applications.

Dr. Hyland is a molecular and developmental biologist. Prior to joining the firm, she was Senior Biopharmaceutical Project Manager - Cell and Gene Therapies for Eurofins-Lancaster Laboratories, where she functioned as a liaison between client R&D scientists and internal laboratory and project management leaders and managed biopharmaceutical testing programs for 3 cell and gene therapy clients. She also has eight years of experience in CRISPR/Cas9 genome editing approaches.

Dr. Hyland earned a Ph.D. in Cell and Molecular Biology from Lehigh University in 2021. She is also a magna cum laude graduate of Moravian University.


  • U.S. Patent and Trademark Office


  • Lehigh University, Ph.D., Cell and Molecular Biology, 2021
  • Moravian University, B.S., magna cum laude, 2015


  • Duane Morris LLP
    - Patent Agent, 2023-present
    - Technical Advisor, 2021-2023
  • Eurofins-Lancaster Laboratories
    - Senior Biopharmaceutical Project Manager - Cell and Gene Therapies, 2021
  • Lehigh University, Department of Biological Sciences
    - Ph.D. Candidate, 2015-2021

Selected Publications

  • Co-author, "Everything Flows Downstream: Novel Signal Transduction Suspects in Cohesinopathies," In prep for submission to Developmental Cell
  • Co-author, "Impaired Cx43 gap junction endocytosis causes cardiovascular defects in zebrafish," Molecular Biology of the Cell, 2021
  • Co-author, "Connexin 43 gap junctional intercellular communication inhibits evx1 expression and joint formation in regenerating fins," Development, 2020